Home/Pipeline/AlphaLISA SureFire® Ultra™

AlphaLISA SureFire® Ultra™

Phosphoprotein detection for drug discovery

N/AActive

Key Facts

Indication
Phosphoprotein detection for drug discovery
Phase
N/A
Status
Active
Company

About TGR BioSciences

Australian immunoassay specialist offering fast, multiplexable CaptSure™ platforms for drug discovery and diagnostics.

View full company profile

Therapeutic Areas